fbpx

Year

2019
Cambridge, UK and Indianapolis, US – 21 October 2019: Acacia Pharma Group plc (the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients, announces that application has been made to Euronext Brussels for the admission of the 9,000 Ordinary Shares of...
They’re not yet 30 but they have already shown outstanding talent, which is why three young researchers are receiving a Lundbeck Foundation Talent Prize. ‘We have three very promising research talents here, and they’ve all impressed us by producing outstanding research results at a young age. But besides publishing copious articles and contributing new knowledge...
SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ — AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced results from a Phase 1 clinical proof of concept study evaluating the use of the Rivelin® bio-adhesive patch in patients with vulvar lichen sclerosus (VLS), a painful genital skin condition that affects up to 3% of post-menopausal women....
Cambridge, UK and Indianapolis, US – 1 October 2019: Acacia Pharma Group plc (the “Company), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients, announces that application has been made to Euronext Brussels for the admission in aggregate of 303,841 Ordinary Shares...
Lund, Sweden, 12:00 pm CET, 30 September 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids. During September, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 76,800 due to the exercise of warrants. As of 30 September 2019, the number of...
How is our gut flora affected when our immune system is compromised during illness? This is the question a team of researchers at Rigshospitalet, University of Copenhagen, would now like to answer by analysing 1,200 faecal samples. The biological samples lie, side by side, in small plastic tubes with airtight lids in the freezer at...
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 26 September 2019: Acacia Pharma Group plc (“Acacia Pharma” or “the Company”), a pharmaceutical company developing and commercializing hospital products for US and international markets, announces that the US Food...
SAN DIEGO, Sept. 24, 2019 /PRNewswire/ — Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, today announced that preclinical data for fosmanogepix (APX001) will be presented at the upcoming scientific conferences IDWeek 2019 in Washington D.C. from October 2-6, 2019, and the 9th Congress on Trends in Medical Mycology Meeting...
Palma, Spain and San Diego, USA, 23 September 2019 – Sanifit, a clinical-stage biopharmaceutical company focused on treatments for progressive vascular calcification disorders, today announced that it has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry. In...
A Brain Prize meeting ended up having a major impact on 29-year-old molecular biologist Camilla Lundbye. She subsequently received a Lundbeck Foundation scholarship and is now taking a PhD at the University of Toronto in Canada, with one of the world’s most prestigious brain researchers as her supervisor. If you want to dance, you need...
1 2 3 4 5 13

News

Seven research institutions receive DKK 20 million for coronavirus research
1. April 2020
How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge